These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 37321416)

  • 1. Plight of CORMs: The unreliability of four commercially available CO-releasing molecules, CORM-2, CORM-3, CORM-A1, and CORM-401, in studying CO biology.
    Bauer N; Yuan Z; Yang X; Wang B
    Biochem Pharmacol; 2023 Aug; 214():115642. PubMed ID: 37321416
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of frequently applied carbon monoxide releasing molecules (CORMs) in typical CO-sensitive model systems - A comparative in vitro study.
    Stucki D; Krahl H; Walter M; Steinhausen J; Hommel K; Brenneisen P; Stahl W
    Arch Biochem Biophys; 2020 Jul; 687():108383. PubMed ID: 32335048
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antithrombotic properties of water-soluble carbon monoxide-releasing molecules.
    Kramkowski K; Leszczynska A; Mogielnicki A; Chlopicki S; Fedorowicz A; Grochal E; Mann B; Brzoska T; Urano T; Motterlini R; Buczko W
    Arterioscler Thromb Vasc Biol; 2012 Sep; 32(9):2149-57. PubMed ID: 22772756
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the effects of CORM-2, CORM-3 and CORM-A1 on coagulation in human plasma.
    Nielsen VG; Garza JI
    Blood Coagul Fibrinolysis; 2014 Dec; 25(8):801-5. PubMed ID: 25058038
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reassessing CORM-A1: redox chemistry and idiosyncratic CO-releasing characteristics of the widely used carbon monoxide donor.
    Bauer N; Yang X; Yuan Z; Wang B
    Chem Sci; 2023 Mar; 14(12):3215-3228. PubMed ID: 36970102
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CORM-A1: a new pharmacologically active carbon monoxide-releasing molecule.
    Motterlini R; Sawle P; Hammad J; Bains S; Alberto R; Foresti R; Green CJ
    FASEB J; 2005 Feb; 19(2):284-6. PubMed ID: 15556971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of Triggerable, Trackable, and Targetable Carbon Monoxide Releasing Molecules.
    Lazarus LS; Benninghoff AD; Berreau LM
    Acc Chem Res; 2020 Oct; 53(10):2273-2285. PubMed ID: 32929957
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A thiol-reactive Ru(II) ion, not CO release, underlies the potent antimicrobial and cytotoxic properties of CO-releasing molecule-3.
    Southam HM; Smith TW; Lyon RL; Liao C; Trevitt CR; Middlemiss LA; Cox FL; Chapman JA; El-Khamisy SF; Hippler M; Williamson MP; Henderson PJF; Poole RK
    Redox Biol; 2018 Sep; 18():114-123. PubMed ID: 30007887
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heme is required for carbon monoxide activation of mitochondrial BK
    Rotko D; Bednarczyk P; Koprowski P; Kunz WS; Szewczyk A; Kulawiak B
    Eur J Pharmacol; 2020 Aug; 881():173191. PubMed ID: 32422186
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Examining the antimicrobial activity and toxicity to animal cells of different types of CO-releasing molecules.
    Nobre LS; Jeremias H; Romão CC; Saraiva LM
    Dalton Trans; 2016 Jan; 45(4):1455-66. PubMed ID: 26673556
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carbon monoxide and its donors - their implications for medicine.
    Adach W; Olas B
    Future Med Chem; 2019 Jan; 11(1):61-73. PubMed ID: 30526059
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sensing a CO-Releasing Molecule (CORM) Does Not Equate to Sensing CO: The Case of DPHP and CORM-3.
    Liu D; Yang X; Wang B
    Anal Chem; 2023 Jun; 95(23):9083-9089. PubMed ID: 37263968
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carbon monoxide releasing molecule 401 (CORM-401) modulates phase I metabolism of xenobiotics.
    Walter M; Stahl W; Brenneisen P; Reichert AS; Stucki D
    Toxicol In Vitro; 2019 Sep; 59():215-220. PubMed ID: 31004742
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elucidation of the CO-Release Kinetics of CORM-A1 by Means of Vibrational Spectroscopy.
    Klein M; Neugebauer U; Schmitt M; Popp J
    Chemphyschem; 2016 Apr; 17(7):985-93. PubMed ID: 26699153
    [TBL] [Abstract][Full Text] [Related]  

  • 15. On the Question of CO's Ability to Induce HO-1 Expression in Cell Culture: A Comparative Study Using Different CO Sources.
    Yang X; Mao Q; Wang B
    ACS Chem Biol; 2024 Mar; 19(3):725-735. PubMed ID: 38340055
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of platelet aggregation by carbon monoxide-releasing molecules (CO-RMs): comparison with NO donors.
    Chlopicki S; Lomnicka M; Fedorowicz A; Grochal E; Kramkowski K; Mogielnicki A; Buczko W; Motterlini R
    Naunyn Schmiedebergs Arch Pharmacol; 2012 Jun; 385(6):641-50. PubMed ID: 22362133
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Water-Soluble Carbon Monoxide-Releasing Molecules (CORMs).
    Khan H; Faizan M; Niazi SUK; Madiha ; Muhammad N; Zhang W
    Top Curr Chem (Cham); 2022 Dec; 381(1):3. PubMed ID: 36515756
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CO-independent modification of K
    Gessner G; Sahoo N; Swain SM; Hirth G; Schönherr R; Mede R; Westerhausen M; Brewitz HH; Heimer P; Imhof D; Hoshi T; Heinemann SH
    Eur J Pharmacol; 2017 Nov; 815():33-41. PubMed ID: 28987271
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell damage following carbon monoxide releasing molecule exposure: implications for therapeutic applications.
    Winburn IC; Gunatunga K; McKernan RD; Walker RJ; Sammut IA; Harrison JC
    Basic Clin Pharmacol Toxicol; 2012 Jul; 111(1):31-41. PubMed ID: 22269084
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction of carbon monoxide-releasing ruthenium carbonyl CORM-3 with plasma fibronectin.
    Aki T; Unuma K; Noritake K; Kurahashi H; Funakoshi T; Uemura K
    Toxicol In Vitro; 2018 Aug; 50():201-209. PubMed ID: 29580987
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.